[Relations between portal and peripheral venous insulin, proinsulin and glucagon concentrations after oral glucose in man]. 1976

B Schulz, and D Michaelis, and M Ziegler, and W Teichmann, and W Nowak, and G Albrecht, and H Bibergeil

During cholecystectomy a catheter was inserted into the V. porta via V. umbilicalis. 7 or 8 days later an oral glucose tolerance test was performed (100 g). Blood glucose, insulin (IRI), proinsulin-like material (PLM), and pancreatic glucagon (IRG) concentrations were determined in portal as well as in peripheral venous blood. 5 out of 6 patients showed a disturbed carbohydrate tolerance in comparison to 53 healthy subjects. The IRI increased promptly after the oral glucose load. The portal IRI-concentrations are significantly enhanced in comparison to the peripheral levels, but between both a positive correlation exists (r = 0.9447; p less than 0.01). PLM was slightly increased in the first 10 minutes. The basal IRG levels were not enhanced. Significant differences between the portal and peripheral IRG concentrations could not be observed. The correlation coefficient was 0.8902. Thus, the peripheral venous concentrations of IRI, PLM and IRG can be used as a diagnostic tool of pancreatic hormone secretion in man.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D011169 Portal Vein A short thick vein formed by union of the superior mesenteric vein and the splenic vein. Portal Veins,Vein, Portal,Veins, Portal
D011236 Prediabetic State The time period before the development of symptomatic diabetes. For example, certain risk factors can be observed in subjects who subsequently develop INSULIN RESISTANCE as in type 2 diabetes (DIABETES MELLITUS, TYPE 2). Prediabetes,Prediabetic States,State, Prediabetic,States, Prediabetic
D011384 Proinsulin A pancreatic polypeptide of about 110 amino acids, depending on the species, that is the precursor of insulin. Proinsulin, produced by the PANCREATIC BETA CELLS, is comprised sequentially of the N-terminal B-chain, the proteolytically removable connecting C-peptide, and the C-terminal A-chain. It also contains three disulfide bonds, two between A-chain and B-chain. After cleavage at two locations, insulin and C-peptide are the secreted products. Intact proinsulin with low bioactivity also is secreted in small amounts.
D005934 Glucagon A 29-amino acid pancreatic peptide derived from proglucagon which is also the precursor of intestinal GLUCAGON-LIKE PEPTIDES. Glucagon is secreted by PANCREATIC ALPHA CELLS and plays an important role in regulation of BLOOD GLUCOSE concentration, ketone metabolism, and several other biochemical and physiological processes. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1511) Glucagon (1-29),Glukagon,HG-Factor,Hyperglycemic-Glycogenolytic Factor,Proglucagon (33-61),HG Factor,Hyperglycemic Glycogenolytic Factor
D005947 Glucose A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement. Dextrose,Anhydrous Dextrose,D-Glucose,Glucose Monohydrate,Glucose, (DL)-Isomer,Glucose, (alpha-D)-Isomer,Glucose, (beta-D)-Isomer,D Glucose,Dextrose, Anhydrous,Monohydrate, Glucose
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D014680 Veins The vessels carrying blood away from the CAPILLARY BEDS. Vein

Related Publications

B Schulz, and D Michaelis, and M Ziegler, and W Teichmann, and W Nowak, and G Albrecht, and H Bibergeil
April 1974, Klinische Wochenschrift,
B Schulz, and D Michaelis, and M Ziegler, and W Teichmann, and W Nowak, and G Albrecht, and H Bibergeil
January 1973, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
B Schulz, and D Michaelis, and M Ziegler, and W Teichmann, and W Nowak, and G Albrecht, and H Bibergeil
January 1973, Acta medica Scandinavica,
B Schulz, and D Michaelis, and M Ziegler, and W Teichmann, and W Nowak, and G Albrecht, and H Bibergeil
March 1974, Diabetes,
B Schulz, and D Michaelis, and M Ziegler, and W Teichmann, and W Nowak, and G Albrecht, and H Bibergeil
June 1975, The Journal of clinical investigation,
B Schulz, and D Michaelis, and M Ziegler, and W Teichmann, and W Nowak, and G Albrecht, and H Bibergeil
May 1970, Diabetes,
B Schulz, and D Michaelis, and M Ziegler, and W Teichmann, and W Nowak, and G Albrecht, and H Bibergeil
June 1995, Masui. The Japanese journal of anesthesiology,
B Schulz, and D Michaelis, and M Ziegler, and W Teichmann, and W Nowak, and G Albrecht, and H Bibergeil
April 1977, European journal of clinical pharmacology,
B Schulz, and D Michaelis, and M Ziegler, and W Teichmann, and W Nowak, and G Albrecht, and H Bibergeil
January 2002, Pancreas,
B Schulz, and D Michaelis, and M Ziegler, and W Teichmann, and W Nowak, and G Albrecht, and H Bibergeil
May 1978, Scandinavian journal of clinical and laboratory investigation,
Copied contents to your clipboard!